Recent News View All News

Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States

Feb 5, 2025 5:30pm EST

Medexus and Ontario's Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada

Feb 4, 2025 7:00am EST

View All News

Recent Events View All Events

Feb 6, 2025 • 8:00 am EST

Third Quarter 2025 Conference Call

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up